OYLER JOHN
SEC CIK 1042047 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | CEO, Dir | 0 | — | $582.32M | 61 | 2021-07-06 | 2026-08-10 |
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
Transactions 61
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-12 17:53 | 2026-08-10+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $359.12 | -240.8K | 0 | -100% | -$86.48M |
| DMT | 2026-07-22 17:03 | 2026-07-20+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $315.28 | -109.7K | 0 | -100% | -$34.59M |
| DT | 2026-07-22 17:03 | 2026-07-20 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $119.96 | +34.0K | 34.0K | New | +$4.08M |
| DT | 2026-07-17 17:36 | 2026-07-17 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $119.96 | +64.6K | 64.6K | New | +$7.75M |
| DMT | 2026-07-17 17:36 | 2026-07-17 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $312.00 | -64.6K | 0 | -100% | -$20.16M |
| DMT | 2026-07-17 17:31 | 2026-07-15+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $145.28 | +283.2K | 166.6K | New | +$41.14M |
| DMT | 2026-07-17 17:31 | 2026-07-15+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $315.56 | -283.2K | 0 | -100% | -$89.35M |
| DMT | 2026-07-14 21:26 | 2026-07-14 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $305.95 | -145.9K | 0 | -100% | -$44.63M |
| DMT | 2026-07-14 21:26 | 2026-07-14 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $54.06 | +133.6K | 133.6K | New | +$7.22M |
| DMT | 2026-07-14 21:25 | 2026-07-10+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $36.90 | +60.2K | 48.5K | New | +$2.22M |
| DMT | 2026-07-14 21:25 | 2026-07-10+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $303.18 | -60.2K | 0 | -100% | -$18.26M |
| M | 2026-06-25 17:15 | 2026-06-23 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $273.78 | -3,410 | 0 | -100% | -$933.6K |
| M | 2026-06-18 17:19 | 2026-06-16 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $265.55 | -3,693 | 0 | -100% | -$980.7K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +177.9K | 5.70M | +3% | $0 |
| DM | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $257.24 | -1,949 | 0 | -100% | -$501.4K |
| M | 2026-06-10 17:22 | 2026-06-08 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $270.56 | -4,940 | 0 | -100% | -$1.34M |
| M | 2026-03-10 | 2026-03-06 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +444.9K | 5.49M | +9% | $0 |
| M | 2025-12-17 | 2025-12-15+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $306.59 | -100.0K | 84.1K | -54% | -$30.66M |
| M | 2025-11-13 | 2025-11-11+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | G - Gift | $0.00 | -1.01M | 7.30M | -12% | $0 |
| M | 2025-09-18 | 2025-09-16 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $325.71 | -27.8K | 4,408 | -86% | -$9.06M |
| M | 2025-07-11 | 2025-07-09 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $253.38 | -27.8K | 0 | -100% | -$7.04M |
| M | 2025-06-25 | 2025-06-23 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $261.61 | -3,174 | 0 | -100% | -$830.4K |
| M | 2025-06-18 | 2025-06-16+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $263.33 | -5,140 | 1,460 | -78% | -$1.35M |
| D | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +185.1K | 8.28M | +2% | $0 |
| M | 2025-06-10 | 2025-06-06 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $252.77 | -5,127 | 400 | -93% | -$1.30M |
| D | 2025-05-13 | 2025-05-09 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | F - Tax | $17.85 | -1.99M | 8.16M | -20% | -$35.53M |
| D | 2025-05-13 | 2025-05-09 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $0.5 | +4.06M | 10.15M | +66% | +$2.03M |
| DM | 2025-03-12 | 2025-03-10 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $242.67 | -41.2K | 39.3K | -51% | -$10.00M |
| DM | 2025-03-12 | 2025-03-10 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $0.9587 | +539.0K | 41.2K | New | +$516.8K |
| D | 2025-03-07 | 2025-03-05 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +201.1K | 4.41M | +5% | $0 |
| DM | 2025-03-07 | 2025-03-06 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $0.9573 | +526.3K | 40.1K | New | +$503.8K |
| DM | 2025-03-07 | 2025-03-06 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $259.15 | -40.1K | 14.8K | -73% | -$10.39M |
| DM | 2025-03-07 | 2025-03-07 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $249.13 | -58.6K | 0 | -100% | -$14.60M |
| DM | 2025-03-07 | 2025-03-07 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $0.9581 | +767.3K | 58.6K | New | +$735.2K |
| DM | 2025-03-05 | 2025-03-03 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale+OE | $244.30 | -101.0K | 95.0K | -52% | -$24.67M |
| DM | 2025-03-05 | 2025-03-03 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $0.9586 | +1.32M | 4.20M | +46% | +$1.27M |
| D | 2024-12-17 | 2024-12-14 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | M - OptEx | $0.5 | +1.30M | 2.98M | +77% | +$650.0K |
| MI | 2024-10-10 | 2024-10-08 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $232.22 | -10.0K | 0 | -100% | -$2.32M |
| M | 2024-10-10 | 2024-10-08 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $232.22 | -6,175 | 4,610 | -57% | -$1.43M |
| M | 2024-06-26 | 2024-06-24 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $159.58 | -2,789 | 0 | -100% | -$445.1K |
| M | 2024-06-20 | 2024-06-17 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $159.35 | -1,281 | 376 | -77% | -$204.1K |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +490.5K | 1.81M | +37% | $0 |
| MI | 2024-04-11 | 2024-04-09+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $149.50 | -50.0K | 2,811 | -95% | -$7.48M |
| M | 2024-03-14 | 2024-03-12+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $167.36 | -50.0K | 500 | -99% | -$8.37M |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +355.6K | 1.97M | +22% | $0 |
| MI | 2023-01-12 | 2023-01-10 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $248.52 | -13.6K | 2,140 | -86% | -$3.38M |
| M | 2023-01-12 | 2023-01-10 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $248.52 | -6,797 | 0 | -100% | -$1.69M |
| M | 2022-12-29 | 2022-12-27+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $224.43 | -3,203 | 0 | -100% | -$718.9K |
| MI | 2022-12-29 | 2022-12-27+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $224.43 | -6,406 | 0 | -100% | -$1.44M |
| M | 2022-11-17 | 2022-11-15 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $206.84 | -25.0K | 23.6K | -51% | -$5.17M |
| MI | 2022-11-17 | 2022-11-15 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $206.82 | -4,928 | 0 | -100% | -$1.02M |
| MI | 2022-09-22 | 2022-09-20+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $152.13 | -50.0K | 0 | -100% | -$7.61M |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +334.0K | 2.07M | +19% | $0 |
| M | 2021-09-16 | 2021-09-14+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $82.04 | -411.8K | 1.74M | -19% | -$33.79M |
| M | 2021-09-02 | 2021-08-31+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $109.77 | -288.6K | 23.5K | -92% | -$31.69M |
| M | 2021-08-05 | 2021-08-04+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $132.34 | -125.3K | 1,600 | -99% | -$16.58M |
| M | 2021-08-05 | 2021-08-03 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $182.37 | -83.4K | 20.5K | -80% | -$15.20M |
| M | 2021-07-22 | 2021-07-20+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $152.13 | -70.9K | 10.2K | -87% | -$10.78M |
| M | 2021-07-22 | 2021-07-22 | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $71.82 | -69.2K | 516 | -99% | -$4.97M |
| M | 2021-07-08 | 2021-07-06+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $117.22 | -123.8K | 1,457 | -99% | -$14.51M |
| M | 2021-07-08 | 2021-07-07+ | ONC | BeOne Medicines Ltd. | OYLER JOHN | CEO, Dir | S - Sale | $94.83 | -67.5K | 10.3K | -87% | -$6.40M |
Purchase Sale Sale after option exercise All abbreviations